3'phosphoinositide‐dependent kinase‐1 is essential for ischemic preconditioning of the myocardium
Open Access
- 31 October 2006
- journal article
- fj express-summaries
- Published by Wiley in The FASEB Journal
- Vol. 20 (14) , 2556-2558
Abstract
Brief periods of ischemia and reperfusion that precede sustained ischemia lead to a reduction in myocardial infarct size. This phenomenon, known as ischemic preconditioning, is mediated by signaling pathway(s) that are yet to be fully defined. 3'‐phosphoinositide‐dependent kinase‐1 (PDK1) has been implicated in numerous cellular processes. However, the involvement of PDK1 in preconditioning has yet to be elucidated. Studying PDK1 is not as straightforward as it is for the majority of kinases, due to the lack of a specific inhibitor of PDK1. Therefore, we have taken advantage of PDK1 hypomorphic mutant mice with reduced expression of PDK1 to study the role of PDK1 in preconditioning. Whole heart and single cell models of preconditioning demonstrated that the hearts and cardiac cells from PDK1 hypomorphic mice could not be preconditioned. The cardioprotective effect of PDK1 was not related to the effect that preconditioning has on sarcolemmal membrane action potential as revealed by di‐8‐ANEPPS, a sarcolemmalpotential sensitive dye, and laser confocal microscopy. In contrast, experiments with JC‐1, a mitochondrial membrane potential‐sensitive dye, has demonstrated that intact PDK1 levels were required for preconditioning‐mediated regulation of mitochondrial membrane potential. Western blotting combined with functional experiments have shown that intact PDK1 levels were required for preconditioning‐induced phosphorylation of protein kinase B (PKB), glycogen synthase kinase‐3β (GSK‐3β), and cardioprotection. We conclude that PDK1 mediates preconditioning in the heart by regulating activating PKB‐GSK‐3β to regulate mitochondrial but not sarcolemmal membrane potential. 3'phosphoinositide‐dependent kinase‐1 (PDK1) is essential for ischemic preconditioning of the myocardium.—Budas, G.R., Sukhodub, A., Alessi, D.R., Jovanovic, A. 3'phosphoinositide‐dependent kinase‐1 is essential for ischemic preconditioning of the myocardium. FASEB J. 20, E1924–E1934 (2006)Keywords
This publication has 46 references indexed in Scilit:
- AMP‐activated protein kinase mediates preconditioning in cardiomyocytes by regulating activity and trafficking of sarcolemmal ATP‐sensitive K+ channelsJournal of Cellular Physiology, 2006
- Overexpression of SUR2A generates a cardiac phenotype resistant to ischemiaThe FASEB Journal, 2006
- The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and diseaseJournal of Molecular and Cellular Cardiology, 2004
- Role of the Mitochondrial Permeability Transition in Myocardial DiseaseCirculation Research, 2003
- Role of sarcolemmal KATP channels in cardioprotection against ischemia/reperfusion injury in miceJournal of Clinical Investigation, 2002
- Insulin signalling and the regulation of glucose and lipid metabolismNature, 2001
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Biphasic Response of Action Potential Duration to Metabolic Inhibition in Rabbit and Human Ventricular Myocytes: Role of Transient Outward Current and ATP-regulated Potassium CurrentJournal of Molecular and Cellular Cardiology, 1996
- Role of ATP sensitive potassium channel in extracellular potassium accumulation and cardiac arrhythmias during myocardial ischaemiaCardiovascular Research, 1994
- Evidence that Translocation of Protein Kinase C is a Key Event During Ischemic Preconditioning of Rabbit MyocardiumJournal of Molecular and Cellular Cardiology, 1994